March 4, 2026
Headlines

Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance

01 mins

GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase in test revenue.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News